Post by L.E.K. Consulting

326,756 followers

China is becoming an increasingly important destination for global biopharma clinical development. In this video, Helen Chen discusses why international companies are moving earlier-stage clinical trials to China — from faster patient enrollment and strong investigator networks to earlier access to Asian patient insights and accelerated commercialization timelines. Watch the full video: https://bit.ly/4x4GRAC #Biopharma #ClinicalTrials #LifeSciences #HealthcareInnovation #LEKConsulting

Post content

Video Content